Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes.
Autoimmune polyglandular syndrome 3 variant (APS3v) refers to the co-occurrence of autoimmune thyroiditis (AITD) and type 1 diabetes (T1D) within the same individual. HLA class II confers the strongest susceptibility to APS3v. We previously identified a unique amino acid signature of the HLA-DR pocket (designated APS3v HLA-DR pocket) that predisposes to APS3v. We hypothesized that both thyroid and islet peptides can be presented by the unique APS3v HLA-DR pocket, triggering AITD + T1D together. To test this hypothesis we screened islet and thyroid peptides for their ability to bind to the APS3v HLA-DR pocket. Virtual screen of all possible thyroglobulin (Tg), thyroid-stimulating hormone receptor (TSHR), thyroid peroxidase (TPO), insulin (Ins), and glutamic acid decarboxylase 65 (GAD65) peptides identified 36 peptides that bound to this unique pocket. In vitro binding assays using baculovirus-produced recombinant APS3v HLA-DR identified 11 thyroid/islet peptides (of the 36 predicted binders) that bound with high affinity. By immunizing humanized HLA-DR3 mice carrying the APS3v HLA-DR pocket we identified 4 peptides (Tg.1571, GAD.492, TPO.758, TPO.338) that were presented by antigen presenting cells and elicited T-cell response. We conclude that both thyroid and islet peptides can bind to this flexible APS3v HLA-DR pocket and induce thyroid and islet specific T-cell responses. These findings set the stage to developing specific inhibitors of the APS3v HLA-DR pocket as a precision medicine approach to treating or preventing APS3v in patients that carry this genetic HLA-DR pocket variant.
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Cheuk Wun
CW
Li
Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Roman
R
Osman
Endocrinology Unit, University of Pisa, Pisa, Italy.
Francesca
F
Menconi
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Erlinda S
ES
Concepcion
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Electronic address: ytomer@montefiore.org.
Yaron
Y
Tomer
D000595:Amino Acid Sequence; D000818:Animals; D015551:Autoimmunity; D001665:Binding Sites; D016207:Cytokines / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology* / Q000378:metabolism; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D005260:Female; D006684:HLA-DR Antigens / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007515:Islets of Langerhans / Q000276:immunology; D051379:Mice; D016688:Mice, Inbred NOD; D008822:Mice, Transgenic; D008958:Models, Molecular; D010455:Peptides / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism; D011485:Protein Binding / Q000276:immunology; D011487:Protein Conformation; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D013961:Thyroid Gland / Q000276:immunology; D013967:Thyroiditis, Autoimmune / Q000276:immunology* / Q000378:metabolism
D016207:Cytokines; D018984:Epitopes, T-Lymphocyte; D006684:HLA-DR Antigens; D010455:Peptides
Autoimmune thyroiditis; Graves' disease; HLA; Hashimoto's disease; Type 1 diabetes
Acta Biomed. 2003 Apr;74(1):9-33
12817789
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
8744570
J Autoimmun. 2005 Nov;25(3):235-43
16263242
J Autoimmun. 2005 Dec;25(4):303-11
16249070
J Clin Endocrinol Metab. 2005 Aug;90(8):4904-11
15928253
J Chem Inf Model. 2011 Feb 28;51(2):326-34
21284404
J Autoimmun. 2009 Nov-Dec;33(3-4):260-9
19811893
Thyroid. 2002 Nov;12(11):977-88
12490075
Clin Immunol Immunopathol. 1997 Sep;84(3):223-43
9281381
J Immunol. 2011 Dec 1;187(11):5921-30
22043012
Thyroid. 2010 Jul;20(7):737-43
20578896
Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16899-903
20837527
J Comput Chem. 2005 Dec;26(16):1668-88
16200636
Hum Immunol. 1994 Apr;39(4):253-60
7520896
J Clin Endocrinol Metab. 1995 May;80(5):1597-604
7745006
Clin Exp Immunol. 1992 Oct;90(1):93-8
1382906
N Engl J Med. 2004 May 13;350(20):2068-79
15141045
Immunome Res. 2010 Nov 13;6:9
21073747
Autoimmunity. 1992;13(1):17-26
1384731
Immunol Rev. 2012 Nov;250(1):32-48
23046121
Clin Exp Immunol. 1990 Nov;82(2):275-83
2242608
J Exp Med. 1993 Jul 1;178(1):27-47
8315383
Diabetologia. 1997 Mar;40(3):332-8
9084973
J Biol Chem. 2009 Dec 4;284(49):34231-43
19776016
J Biol Chem. 2016 Feb 19;291(8):4079-90
26703475
Immunology. 2007 Oct;122(2):261-7
17535305
J Autoimmun. 2010 Aug;35(1):45-51
20303712
Endocrinol Metab Clin North Am. 2004 Mar;33(1):1-16, vii
15053891
Lancet. 1994 Jun 25;343(8913):1607-8
7911924
J Exp Med. 1996 Sep 1;184(3):1167-72
9064334
PLoS One. 2014 Nov 18;9(11):e112882
25405480
JAMA. 2014 May 7;311(17):1778-86
24794371
Diabetes Care. 2000 Oct;23(10):1516-26
11023146
J Chem Theory Comput. 2012 Sep 11;8(9):3314-21
26605738
J Clin Endocrinol Metab. 2009 Apr;94(4):1458-66
19141582
J Immunol. 2013 Nov 15;191(10):5074-84
24123687
Immunogenetics. 1994;40(2):104-8
8026858
Clin Exp Immunol. 1991 Oct;86(1):56-60
1717189
Immunology. 2013 Mar;138(3):269-79
23228173
Curr Protoc Immunol. 2007 Aug;Chapter 15:15.7.1-15.7.21
18432986
Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7415-9
1714602
Endocr Rev. 2008 Oct;29(6):697-725
18776148
J Autoimmun. 2015 Jun;60:32-9
25936594
J Med Chem. 2004 Oct 7;47(21):4989-97
15456243
J Autoimmun. 2001 Aug;17(1):7-15
11488633
Clin Exp Immunol. 1999 Jul;117(1):30-7
10403912
Nature. 1995 Nov 30;378(6556):457-62
7477400